相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Higher densities of tumour-infiltrating lymphocytes and CD4+ T cells predict recurrence and progression of ductal carcinoma in situ of the breast
Aye Aye Thike et al.
HISTOPATHOLOGY (2020)
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Michael S. Toss et al.
BRITISH JOURNAL OF CANCER (2020)
Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.
Melody A. Cobleigh et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Tumour-infiltrating lymphocytes in ductal carcinomain situ(DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score
Miglena Komforti et al.
HISTOPATHOLOGY (2020)
Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
Milim Kim et al.
BREAST CANCER RESEARCH (2020)
Prognostic role of immune infiltrates in breast ductal carcinoma in situ
Xiao-Yang Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial
Aniko Kovacs et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS)
Farbod Darvishian et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer
Emi Ishigami et al.
BREAST CANCER (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
Marie Beguinot et al.
BMC CANCER (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
Michael S. Toss et al.
MODERN PATHOLOGY (2018)
Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
Marie Colombe Agahozo et al.
MODERN PATHOLOGY (2018)
Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression
Andrew C. Nelson et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2018)
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
G. Pruneri et al.
ANNALS OF ONCOLOGY (2017)
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
Michael J. Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar et al.
CANCER DISCOVERY (2017)
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
Wouter Hendrickx et al.
ONCOIMMUNOLOGY (2017)
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features
Shona Hendry et al.
CLINICAL CANCER RESEARCH (2017)
Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytes
Michi Morita et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Richard G. Margolese et al.
LANCET (2016)
Treatment of low-risk ductal carcinoma in situ: is nothing better than something?
John R. Benson et al.
LANCET ONCOLOGY (2016)
The immune microenvironment of breast ductal carcinoma in situ
Elizabeth Thompson et al.
MODERN PATHOLOGY (2016)
The ratio of CD8(+)/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ
Michaela Semeraro et al.
ONCOIMMUNOLOGY (2016)
Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer
Edith A. Perez et al.
JAMA ONCOLOGY (2016)
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis
Yan Mao et al.
PLOS ONE (2016)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Immune responses to cancer: are they potential biomarkers of prognosis?
Theresa L. Whiteside
FRONTIERS IN ONCOLOGY (2013)
Biologic and Immunologic Effects of Preoperative Trastuzumab for Ductal Carcinoma In Situ of the Breast
Henry M. Kuerer et al.
CANCER (2011)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Basement Membranes: Cell Scaffoldings and Signaling Platforms
Peter D. Yurchenco
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
Sara A. Lari et al.
JOURNAL OF CANCER (2011)
The Tumor-Immune Microenvironment and Response to Radiation Therapy
Stephen L. Shiao et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
分享论文
